This document sets out the sickle cell and thalassaemia (SCT) screening programme's newborn outcomes project.
PDF, 82.1KB, 1 page
This file may not be suitable for users of assistive technology. Request an accessible format.
If you use assistive technology (such as a screen reader) and need a version of this document in a more accessible format, please email firstname.lastname@example.org. Please tell us what format you need. It will help us if you say what assistive technology you use.
This publication sets out the newborn outcomes project pathway for healthcare professionals working in sickle cell and thalassaemia (SCT) screening.
The document includes actions for:
- babies with a newborn blood spot screen positive result
- clinical presentation of an affected child or infant
- the death of an unflagged baby